Lysogene's IPO

Lysogene raised a round of funding on February 09, 2017. Investors include Public.

Lysogene is a clinical stage biotechnology company committed to the development of innovative therapies for patients affected with rare disorders and high unmet medical needs. Lysogene's team translat…

Articles about Lysogene's IPO: